|
|
||||||||
1Department of Internal Medicine, University of Iowa Roy J. and Lucille A. Carver College of Medicine; and 2Department of Otolaryngology, Head and Neck Surgery, University of Iowa Hospitals and Clinics, Iowa City, Iowa
Submitted 30 December 2005 ; accepted in final form 1 February 2006
A clinical case documented a reversible change in airway epithelial differentiation that coincided with the initiation and discontinuation of trastuzumab, an anti-erbB2 antibody. This prompted the investigation into whether blocking the erbB2 receptor alters differentiation of the airway epithelium. To test this hypothesis, we treated an in vitro model of well-differentiated human airway epithelia with trastuzumab or heregulin-
, an erbB ligand. In addition, coculturing with human lung fibroblasts tested whether in vivo subepithelial fibroblasts function as an endogenous source of ligands able to activate erbB receptors expressed by the overlying epithelial cells. Epithelia were stained with hematoxylin and eosin and used for morphometric analysis. Trastuzumab treatment decreased the ciliated cell number by 49% and increased the metaplastic, flat cell number by 640%. Heregulin-
treatment increased epithelial height and decreased the number of metaplastic and nonciliated columnar cells, whereas it increased the goblet cell number. We found that normal human lung fibroblasts express transforming growth factor-
, heparin-binding epidermal-like growth factor, epiregulin, heregulin-
, and amphiregulin, all of which are erbB ligands. Cocultures of airway epithelia with primary fibroblasts increased epithelial height comparable to that achieved following heregulin-
treatment. These data show that erbB2 stimulation is required for maintaining epithelial differentiation. Furthermore, the mesenchyme underlying the airway epithelium secretes a variety of erbB ligands that may direct various pathways of epithelial differentiation.
trastuzumab; fibroblasts
This article has been cited by other articles:
![]() |
N. T. N. Trinh, A. Prive, L. Kheir, J.-C. Bourret, T. Hijazi, M. G. Amraei, J. Noel, and E. Brochiero Involvement of KATP and KvLQT1 K+ channels in EGF-stimulated alveolar epithelial cell repair processes Am J Physiol Lung Cell Mol Physiol, October 1, 2007; 293(4): L870 - L882. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. M. Myerburg, J. D. Latoche, E. E. McKenna, L. P. Stabile, J. S. Siegfried, C. A. Feghali-Bostwick, and J. M. Pilewski Hepatocyte growth factor and other fibroblast secretions modulate the phenotype of human bronchial epithelial cells Am J Physiol Lung Cell Mol Physiol, June 1, 2007; 292(6): L1352 - L1360. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. LeSimple, I. van Seuningen, M.-P. Buisine, M.-C. Copin, M. Hinz, W. Hoffmann, R. Hajj, S. L. Brody, C. Coraux, and E. Puchelle Trefoil Factor Family 3 Peptide Promotes Human Airway Epithelial Ciliated Cell Differentiation Am. J. Respir. Cell Mol. Biol., March 1, 2007; 36(3): 296 - 303. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Puchelle, J.-M. Zahm, J.-M. Tournier, and C. Coraux Airway Epithelial Repair, Regeneration, and Remodeling after Injury in Chronic Obstructive Pulmonary Disease Proceedings of the ATS, November 1, 2006; 3(8): 726 - 733. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |